Detalles de la búsqueda
1.
Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizer.
Oncologist
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38767987
2.
Ribociclib-Induced Cutaneous Adverse Events in Metastatic HR+/HER2- Breast Cancer: Incidence, Multidisciplinary Management, and Prognostic Implication.
Oncologist
; 29(6): 484-492, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38242689
3.
Ovarian Suppression: Early Menopause and Late Effects.
Curr Treat Options Oncol
; 25(4): 523-542, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38478329
4.
Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysis.
Eur J Cancer
; 197: 113478, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38103328
5.
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer.
Biomedicines
; 12(3)2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38540113
6.
The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial.
Clin Breast Cancer
; 2024 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514306
7.
The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy.
Cancers (Basel)
; 16(2)2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254865
8.
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions.
Crit Rev Oncol Hematol
; 196: 104324, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38462150
9.
HR+/HER2- de novo metastatic breast cancer: a true peculiar entity?
Drugs Context
; 122023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36926051
10.
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer.
Cancers (Basel)
; 15(11)2023 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296893
11.
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib.
J Clin Med
; 12(5)2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902563
12.
Unlocking the Potential of Circulating miRNAs in the Breast Cancer Neoadjuvant Setting: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 15(13)2023 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444533
13.
Opportunities and Challenges of Synthetic Data Generation in Oncology.
JCO Clin Cancer Inform
; 7: e2300045, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535875
14.
Clinical Review on the Management of Breast Cancer Visceral Crisis.
Biomedicines
; 11(4)2023 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37189701
15.
Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy.
Cancers (Basel)
; 15(6)2023 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980605
16.
Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to Pave.
Cancers (Basel)
; 15(5)2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900200
17.
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Nutrients
; 15(1)2023 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36615868
18.
Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients.
Breast
; 69: 323-329, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37001289
19.
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab.
Crit Rev Oncol Hematol
; 190: 104089, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37562696
20.
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
NPJ Breast Cancer
; 9(1): 27, 2023 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37069173